Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04291378
NA

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

Sponsor: Danish Breast Cancer Cooperative Group

View on ClinicalTrials.gov

Summary

The majority of early breast cancer patients are treated with adjuvant radiation therapy (RT) as part of their multimodal therapy. The aim of the RT is to lower the risk of local, regional and distant failure and improve survival. Modern RT is been provided with photon therapy. Now, more proton therapy facilities are opened, including in Denmark. Proton RT may have the potential to cause lower dose to heart and lung during breast RT. This trial will randomise patients between standard photon RT versus experimental proton RT. The primary endpoint is 10 year risk of heart disease.

Official title: The DBCG Proton Trial. Adjuvant Breast Proton Radiation Therapy for Early Breast Cancer Patients: The Skagen Trial 2, a Clinically Controlled Randomised Phase III Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1502

Start Date

2020-06-01

Completion Date

2037-06-01

Last Updated

2020-10-08

Healthy Volunteers

No

Interventions

RADIATION

Proton versus photon radiation therapy

The intervention is proton radiation therapy versus photon radiation therapy

Locations (8)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus, Denmark

The Danish Breast Cancer Cooperative Group

Copenhagen, Denmark

Rigshospitalet

Copenhagen, Denmark

Herlev Hospital

Herlev, Denmark

Naestved Hospital

Næstved, Denmark

Odense University Hospital

Odense, Denmark

Vejle Hospital

Vejle, Denmark